Huliq News Tagged: "vaccine"

Syndicate content

Footrot vaccine closer than ever

Monash University scientists have started clinical trials to find a successful vaccine against footrot in sheep.

View Comment 40 reads

Footrot vaccine closer than ever

Monash University scientists have started clinical trials to find a successful vaccine against footrot in sheep.

Get the full story...

New pathogen from pigs' stomach ulcers

Scientists have isolated a new bacterium in pigs' stomachs thanks to a pioneering technique, offering hope of new treatments to people who suffer with stomach ulcers, according to research published in the June issue of the International Journal of Systematic and Evolutionary Microbiology.

Get the full story...

CSC's Dynport Vaccine Company To Continue Plague Vaccine Development

CSC (NYSE: CSC) announced today that DynPort Vaccine Company LLC (DVC), a CSC company, has been notified by the Department of Defense (DoD) that all future funding for advanced development of plague vaccine will be allocated to the existing DVC contract with the Joint Project Manager Chemical, Biological and Medical Systems’ Joint Vaccine Acquisition Program (JVAP) Joint Product Management Office.

Get the full story...

Examining the Avian Flu: From Pandemic Planning to Vaccine Development

The journal Respirology has launched a special supplementary issue on the avian influenza. Published by Wiley-Blackwell, the collection of papers present an inclusive insight into the threat of the avian influenza pandemic by addressing a wide range of topics including the basic biology of the virus, updates on laboratory diagnosis and influenza anti-viral, treatment options, and pandemic planning.

Get the full story...

Hib Vaccine Recall By Merck Due To Contamination

Merck says it voluntarily recalls Hib vaccine due to contamination in the equipment in which the vaccine is made. Merck Hib vaccine recall includes around 1.2 million doses.

Get the full story...

Smoking Cessation Drugs Market Set to Reach $1.5 Billion

Now Viewed as a Mainstream Healthcare Market, Smoking Cessation Drugs Set to Reach $1.5 Billion. Demand Factors, Emerging Products Analyzed by Applied Data Research.

Get the full story...

Key Injectable Drug Markets Evolve as New Biologicals Take Center Stage

Greystone Associates Analyzes the Impact of Protein and Peptide Drugs on Chronic Disease Segments

Get the full story...

LigoCyte Offers New Immunization

LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic Protection Against Influenza Challenge With Virus-Like Particle Immunization

Get the full story...

How Long WouldTake for Vaccines To Protect People?

In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune response? A new national study led by Saint Louis University School of Medicine will attempt to answer this question.

Get the full story...

77 Million Doses of Vaccine Supply Delivered

The Centers for Disease Control and Prevention (CDC) today announced the designation of the week after Thanksgiving as National Influenza Vaccination Week. This year, National Influenza Vaccination Week will run from November 27 to December 3.

Read the full story

Shingles Vaccine Slashes Risk

People ages 60 and older should be given a new vaccine to reduce their risk of shingles, a painful flare-up of chickenpox virus, a panel of health experts said Wednesday.

Shingles strikes about 1 million people a year, and the risk increases with age. It is caused by the varicella virus, which causes chickenpox, usually in childhood. The virus then lies dormant, often for decades, hiding in nerves along the spinal cord.

Login or Join Huliq today!